Incannex Healthcare (IXHL) Share-based Compensation (2023 - 2026)
Incannex Healthcare's (IXHL) quarterly Share-based Compensation came in at -$1.5 million in Q1 2026, down 252.88% year-on-year from $960201.3 in Q1 2025, and up 35.59% quarter-over-quarter from -$2.3 million in Q4 2025.
Incannex Healthcare (IXHL) Share-based Compensation (2023 - 2026) Analysis & Trends
Incannex Healthcare has disclosed Share-based Compensation across 4 years of filings, most recently posting -$1.5 million for Q1 2026.
- Share-based Compensation for Q1 2026 came in at -$1.5 million, down 252.88% year-over-year; the trailing twelve-month figure through Mar 2026 was $177000.0 (down 94.0% YoY), and the FY2025 annual result was $2.6 million, down 70.78% from the prior year.
- Share-based Compensation came in at -$1.5 million for Q1 2026 at Incannex Healthcare, up from -$2.3 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $3.3 million in Q2 2024 to a low of -$2.3 million in Q4 2025.
- The 4-year median for Share-based Compensation is $518000.0 (2023), against an average of $751153.8.
- Across the five-year window, Share-based Compensation soared 545.56% in 2024 and sank 423.91% in 2025, its largest moves.
- Incannex Healthcare's Share-based Compensation stood at $3.3 million in 2023, then tumbled by 113.3% to -$435000.0 in 2024, then tumbled by 423.91% to -$2.3 million in 2025, then surged by 35.59% to -$1.5 million in 2026.
- The last three Share-based Compensation figures came in at -$1.5 million (Q1 2026), -$2.3 million (Q4 2025), and $2.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 43.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 25.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 33.90 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -395,114.54 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 57.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 21.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 36.33 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 36.86 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 16.04 Mn |
| 10 | Incannex Healthcare | 45.81 Mn | 45.81 Mn | - | -1.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.47 Mn |
| Mar 31, 2026 | -1.47 Mn |
| Dec 31, 2025 | -2.28 Mn |
| Dec 31, 2025 | -2.28 Mn |
| Sep 30, 2025 | 2.63 Mn |
| Sep 30, 2025 | 2.63 Mn |
| Jun 30, 2025 | 1.30 Mn |
| Jun 30, 2025 | 1.30 Mn |
| Mar 31, 2025 | -416,000.00 |
| Mar 31, 2025 | -416,000.00 |
| Dec 31, 2024 | -435,000.00 |
| Dec 31, 2024 | -435,000.00 |
| Sep 30, 2024 | 459,000.00 |
| Sep 30, 2024 | 459,000.00 |
| Jun 30, 2024 | 3.34 Mn |
| Jun 30, 2024 | 3.34 Mn |
| Mar 31, 2024 | 2.12 Mn |
| Mar 31, 2024 | 2.12 Mn |
| Dec 31, 2023 | 3.27 Mn |
| Dec 31, 2023 | 3.27 Mn |